BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lopez R, Arnulf I, Drouot X, Lecendreux M, Dauvilliers Y. French consensus. Management of patients with hypersomnia: Which strategy? Revue Neurologique 2017;173:8-18. [DOI: 10.1016/j.neurol.2016.09.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Lammers GJ. Drugs Used in Narcolepsy and Other Hypersomnias. Sleep Medicine Clinics 2022. [DOI: 10.1016/j.jsmc.2022.06.005] [Reference Citation Analysis]
2 Arnulf I, Leu-Semenescu S, Dodet P. Precision Medicine for Idiopathic Hypersomnia. Sleep Med Clin 2022;17:379-98. [PMID: 36150801 DOI: 10.1016/j.jsmc.2022.06.016] [Reference Citation Analysis]
3 Zhang M, Thieux M, Inocente CO, Vieux N, Arvis L, Villanueva C, Lin JS, Plancoulaine S, Guyon A, Franco P. Characterization of rapid weight gain phenotype in children with narcolepsy. CNS Neurosci Ther 2022;28:829-41. [PMID: 35212159 DOI: 10.1111/cns.13811] [Reference Citation Analysis]
4 Leclair-visonneau L. Orientation diagnostique devant une plainte d’hypersomnolence. La Revue de Médecine Interne 2022. [DOI: 10.1016/j.revmed.2022.01.004] [Reference Citation Analysis]
5 González M. Hipersomnia idiopática: desconocida y polimórfica. Revista Médica Clínica Las Condes 2021;32:584-90. [DOI: 10.1016/j.rmclc.2021.09.005] [Reference Citation Analysis]
6 Bogan RK, Thorpy MJ, Dauvilliers Y, Partinen M, Del Rio Villegas R, Foldvary-Schaefer N, Skowronski R, Tang L, Skobieranda F, Šonka K. Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy. Sleep 2021;44:zsaa206. [PMID: 33184650 DOI: 10.1093/sleep/zsaa206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
7 Jennum PJ, Plazzi G, Silvani A, Surkin LA, Dauvilliers Y. Cardiovascular disorders in narcolepsy: Review of associations and determinants. Sleep Med Rev 2021;58:101440. [PMID: 33582582 DOI: 10.1016/j.smrv.2021.101440] [Cited by in Crossref: 2] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
8 Spruyt K. Narcolepsy Presentation in Diverse Populations: an Update. Curr Sleep Med Rep 2020;:1-12. [PMID: 33251089 DOI: 10.1007/s40675-020-00195-7] [Reference Citation Analysis]
9 Blattner MS, Day GS. Sleep Disturbances in Patients with Autoimmune Encephalitis. Curr Neurol Neurosci Rep 2020;20:28. [PMID: 32524504 DOI: 10.1007/s11910-020-01048-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
10 Weibel S, Menard O, Ionita A, Boumendjel M, Cabelguen C, Kraemer C, Micoulaud-Franchi JA, Bioulac S, Perroud N, Sauvaget A, Carton L, Gachet M, Lopez R. Practical considerations for the evaluation and management of Attention Deficit Hyperactivity Disorder (ADHD) in adults. Encephale 2020;46:30-40. [PMID: 31610922 DOI: 10.1016/j.encep.2019.06.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
11 Arnulf I, Leu-semenescu S, Dodet P. Precision Medicine for Idiopathic Hypersomnia. Sleep Medicine Clinics 2019;14:333-50. [DOI: 10.1016/j.jsmc.2019.05.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
12 Castelnovo A, Lopez R, Proserpio P, Nobili L, Dauvilliers Y. NREM sleep parasomnias as disorders of sleep-state dissociation. Nat Rev Neurol 2018;14:470-81. [PMID: 29959394 DOI: 10.1038/s41582-018-0030-y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 16.7] [Reference Citation Analysis]
13 Vodovar D, Duchêne A, Wimberley C, Leroy C, Pottier G, Dauvilliers Y, Giaume C, Lin JS, Mouthon F, Tournier N, Charvériat M. Cortico-Amygdala-Striatal Activation by Modafinil/Flecainide Combination. Int J Neuropsychopharmacol 2018;21:687-96. [PMID: 29635319 DOI: 10.1093/ijnp/pyy027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
14 Peter-derex L. Patologie del sonno. EMC - Neurologia 2019;19:1-17. [DOI: 10.1016/s1634-7072(19)42492-6] [Reference Citation Analysis]
15 Abad VC. An evaluation of sodium oxybate as a treatment option for narcolepsy. Expert Opinion on Pharmacotherapy 2019;20:1189-99. [DOI: 10.1080/14656566.2019.1617273] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
16 Lammers GJ. Drugs Used in Narcolepsy and Other Hypersomnias. Sleep Med Clin 2018;13:183-9. [PMID: 29759269 DOI: 10.1016/j.jsmc.2018.02.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
17 Evangelista E, Lopez R, Dauvilliers Y. Update on treatment for idiopathic hypersomnia. Expert Opinion on Investigational Drugs 2018;27:187-92. [DOI: 10.1080/13543784.2018.1417385] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
18 Dauvilliers Y, Evangelista E, de Verbizier D, Barateau L, Peigneux P. [18F]Fludeoxyglucose-Positron Emission Tomography Evidence for Cerebral Hypermetabolism in the Awake State in Narcolepsy and Idiopathic Hypersomnia. Front Neurol 2017;8:350. [PMID: 28775709 DOI: 10.3389/fneur.2017.00350] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
19 Dauvilliers Y, Charnet P. Reply to "Rigor, reproducibility and in vitro CSF assays: The devil in the details". Ann Neurol 2017;81:907-10. [PMID: 28439988 DOI: 10.1002/ana.24939] [Reference Citation Analysis]